Last checked at 
5 Aug 2021 13:00
LEI: 549300Q7EXQQH6KF7Z84
5 August 2021
RTW VENTURE FUND LIMITED
(the "Company")
Transfer of Ordinary Shares to the Premium Segment of the London Stock Exchange
Further to its announcement on 30 July 2021, RTW Venture Fund Limited expects the admission of its ordinary shares to listing on the Official List of the Financial Conduct Authority and to trading on the Premium Segment of the London Stock Exchange to become effective at 8:00am tomorrow, 6 August 2021.
For further information please contact:
For Further Information
RTW Investments, LP +1 (646) 597 6980Stephanie Sirota, Chief Business Officer
Alexandra Taracanova, PhD, Director of Investor Relations
Julia Enright, Senior Business Development Associate
Elysium Fund Management Limited +44 (0) 14 8181 0100
Joanna Duquemin Nicolle, Chief Executive Officer
Sadie Morrison, Managing Director
J.P. Morgan Cazenove +44 (0)20 7742 4000
William Simmonds / Jérémie Birnbaum (Corporate Finance)
James Bouverat / Liam MacDonald-Raggett (Sales)
Barclays +44 (0)20 7623 2323
Tom Swerling
Andrew Tusa
About RTW Venture Fund Limited:
RTW Venture Fund Limited (LSE: RTW) is an investment fund focused on identifying transformative assets with high growth potential across the biopharmaceutical and medical technology sectors. Driven by a long-term approach to support innovative businesses, RTW Venture Fund invests in companies developing next-generation therapies and technologies that can significantly improve patients' lives.
RTW Venture Fund Limited is managed by RTW Investments, LP, a leading healthcare-focused entrepreneurial investment firm with deep scientific expertise and a strong track record of supporting companies developing life-changing therapies.